ClinicalTrials.gg
Status unknownNCT05831137Updated Apr 26, 2023

Cryoanalgesia Aplication Time Optimization During Nuss Procedure

An interventional study of shorter cryoanalgesia in Funnel Chest and Excavatum, Pectus, sponsored by Pomeranian Medical University Szczecin. Status unknown at 1 site in Poland. Open to participants aged 10 Years and older. Per ClinicalTrials.gov, last updated 2023-04-26.

Sponsored by Pomeranian Medical University Szczecin · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
10 Years and older
Sex
All
01

Study summary

This study compared standard therapy (multimodal analgesia with 2 minutes cryoanalgesia) versus a novel approach (multimodal analgesia with 1 minute cryoanalgesia) in subject undergoing minimal invasive modyfied Nuss procedure with thoracoscopy.

Read the detailed description

Funnel chest deformation may be a great challenge for therapeutic teams due to severe pain in the postoperative period as well as chronic pain.

2 minutes per one intercostal nerve aplication cryoanalgesia as a part of multimodal analgesia is a standard protocol in many countries.

This Prospective Non-Randomized Study is a single institution pilot study designed to compare standard therapy (control side: multimodal analgesia with 2 minutes cryoanalgesia) versus a novel approach (multimodal analgesia with 1 minute cryoanalgesia) in each patient to address the need for better management of acute and long-term pain in the pediatric population diagnosed with funnel-chest and treated using the modyfied Nuss method.

All of the patients will receive a standard care according to Polish guidelines: multimodal analgesia with regional analgesia (bilateral erector spine plane block) with cryoanalgesia. The right intercostal nerves will be treated with 2 minutes cryoanalgesia (control side). The left side of the chest (left intercostal nerves) will be treated with 1 minute cryoanalgesia (intervention side).

The intraoperative cryoanalgesia will be performed using the Cryo-S Painless device (Metrum - Cryoflex Polska Limited).

The study will assess the effectiveness of shorter aplication duration time of cryoanalgesia as a method of acute and long-term pain control and safety of the method.

Specific Aim: To determine if, compared with current 2 minutes cryoanalgesia protocol, 1 minute aplication time of cryoanalgesia is effective at the same level when consider pain control and postoperative functioning in each patient.

The results were compared in terms of demographics, right versus left side of the chest pain levels, quality and length of rehabilitation and patient satisfaction using the Quality of Life by modyfied Nuss questionnaire.

02

Conditions studied

  • Funnel Chest
  • Excavatum, Pectus

Browse trials for

Keywords

  • nuss procedure
  • cryoanalgesia
03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 46 interventional studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

Pomeranian Medical University Szczecin is the lead sponsor of 69 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients undergoing pectus excavatum repair with modyfied minimal invasive thoracoscopic Nuss technique
  • informed concent signed for cryolesia

Exclusion criteria

Exclusion Criteria:

  • age 9 years or below
  • refuse to receive cryoanalgesia or regional anaesthesia as a primary pain relief
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    intervention side

    duration of intercostal nerves cryolesia: 1 minute per left nerve

    Procedure: shorter cryoanalgesia

  • No intervention
    control side

    duration of intercostal nerves cryolesia: 2 minute per right nerve

Interventions

  • Procedureshorter cryoanalgesia

    duration time of cryoanalgesia

06

What researchers measure

Primary outcomes

  1. The worse pain occurrence during first 24 hours after operation.

    numeric pain score, range from 0 to 10

    Time frame: up to 24 hours after operation

Secondary outcomes

  1. thoracic hypoaesthesia occurrence

    cold test assessment (yes / no)

    Time frame: up to 24 hours after operation

  2. residual wound or chest pain occurrence

    the chest or wound chronic pain occurrence

    Time frame: postoperative months 1,3

  3. duration of hospitalization

    the lengh of the time in days spent in the hospital

    Time frame: estimated 4 days

07

Study locations

1 of 1 sites recruiting
  • Pomeranian Medical University
    Szczecin, 71-252, Poland
    Recruiting
08

References and documents

Publications

  • Zeineddin S, Goldstein SD, Linton S, DeBoer C, Alayleh A, Ortiz I, Sands L, Kujawa S, Suresh S, Ghomrawi H, Abdullah F. Effectiveness of one minute per level intercostal nerve cryoablation for postoperative analgesia after surgical correction of pectus excavatum. J Pediatr Surg. 2023 Jan;58(1):34-40. doi: 10.1016/j.jpedsurg.2022.09.032. Epub 2022 Sep 26. PubMed 36283847 ↗

Individual participant data

Plan to share: Yes — We invite others researchers to collaboration as multicenter study

Supporting information: Study protocol

Time frame: up to 12 months from the beginning of the study

Access criteria: by contacy to the Principal Investigator

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Jun 2023, 2 months after the start.

Of 31 interventional studies with no phase under Funnel Chest, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 68. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2023
First posted
Apr 26, 2023
StartActual
Mar 31, 2023
Primary completionEst.
Jun 10, 2023
CompletionEst.
Jul 10, 2023
Last update
Apr 26, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05831137
Lead sponsor
Pomeranian Medical University Szczecin
Responsible party
Sponsor
First posted
Apr 26, 2023
Start date
Mar 31, 2023
Primary completion
Jun 10, 2023 (estimated)
Completion
Jul 10, 2023 (estimated)
Last update
Apr 26, 2023

Study contacts

Jowita Biernawska, MD PhD
Contact
lisienko@wp.pl
+48501337073
Slawomir Zacha, MD PhD
Contact
sekozacha@gmail.com
+48513100813
Jowita Biernawska, MD PhD
study director · Pomeranian Medical Universitet Szczecin

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion